Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

[18F]-Fluselenamyl PET Imaging for Cardiac Amyloidosis (FSA-CA)

NCT07771621 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT07771621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07771621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
[18F]-Fluselenamyl PET Imaging for Cardiac Amyloidosis (FSA-CA)
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
January 14, 2026
Completion date
December 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac amyloidosis